Simultaneously Inactivating SRC and AKT by Saracatinib/Capivasertib Co-Delivery Nanoparticles to Improve the Efficacy of Anti-SRC Therapy in Head and Neck Squamous Cell Carcinoma

Journal of Hematology and Oncology - United Kingdom
doi 10.1186/s13045-019-0827-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Biomarkers Predict P53 Gene Therapy Efficacy in Recurrent Squamous Cell Carcinoma of the Head and Neck

Clinical Cancer Research
Cancer ResearchOncology
2009English

Co-Targeting EGFR and IKKβ/NF-κB Signalling Pathways in Head and Neck Squamous Cell Carcinoma: A Potential Novel Therapy for Head and Neck Squamous Cell Cancer

British Journal of Cancer
Cancer ResearchOncology
2018English

Head and Neck: Oral Squamous Cell Carcinoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Analysis of PIK3CA and Akt/Protein Kinase B in Head and Neck Squamous Cell Carcinoma

Oncology Reports
MedicineCancer ResearchOncology
2007English

Cutaneous Squamous Cell Carcinoma of the Head and Neck

Journal of Skin Cancer
DermatologyOncology
2011English

Head and Neck Squamous Cell Carcinoma Survivorship Care

2019English

Immunotherapy for Head and Neck Squamous Cell Carcinoma

Memo - Magazine of European Medical Oncology
OncologyHematology
2016English

Head and Neck Squamous Cell Carcinoma in Pregnant Women

Laryngoscope
Otorhinolaryngology
2011English

SATB2 Augments ΔNp63α in Head and Neck Squamous Cell Carcinoma

EMBO Reports
BiochemistryGeneticsMolecular Biology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy